Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations is a research paper published in Kidney International (2021). On theSindex it has a DataRank of 0.701. It has been cited 13 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.305
From 9 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
American Heart Association
Grant: 858512
National Institutes of Health
Grant: K08 HL145138
U.S. Department of Veterans Affairs
Grant: lO1 BXOO4468
National Institutes of Health
Grant: 5K08HL145138-02
The role of energy sensor signaling in mitochondrial cardiomyopathy
FWCI
1.53
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals